PMV Tina Fund
VC Fund
PMV Tina Fund is a venture capital firm that specializes in growth capital investments.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries PMV Tina Fund invests in
Stages PMV Tina Fund invests in
Countries PMV Tina Fund invests in
Round sizes
Round size
- Series D
- $22M–$38M
Investment Focus
Industry
- Manufacturing 3 (50%)
- Industrial 2 (33%)
- Eyewear 1 (17%)
- Printing 1 (17%)
- Wearables 1 (17%)
Stage
- Series D 2 (33%)
- Series A 1 (17%)
- Series E 1 (17%)
- Series F 1 (17%)
- Venture - Series Unknown 1 (17%)
Country
- Belgium 1 (17%)
- Switzerland 1 (17%)
- United States 1 (17%)
- The Netherlands 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| FRX Innovations is an industrial company that manufactures Nofia polyphosphonates, a type of fire-resistant plastics. The company is in the growth phase of is commercializing a novel family of non-halogen, transparent, high melt flowing, fire-resistant plastics. It delivers high value-added solutions for fabric/textile, electrical,electronics, mass transit, and building and construction markets. FRX Polymers is headquartered in Chelmsford, MA. | $22M / Series D / Sep 13, 2016 | ||
| Borit delivers components for fuel cells and electrolyzes. By developing a production infrastructure of ultra-thin metal bipolar plate assemblies and by providing metal forming, cutting, welding, coating, and sealing, they contribute to the clean energy economy. | $9.1M / Venture - Series Unknown / Dec 30, 2014 | ||
| Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexeddetection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland. | $70.8M / Series F / Sep 04, 2014 | ||
| Luxexcel is the only company in the world with the technology to 3D print lenses. Luxexcel is on a path to open a new era in eyewear with custom quality prescription lenses. And opening up a new vision on smart eyewear by enabling technology partners to develop unique lenses. Luxexcel has developed and owns all components necessary to enable ourcustomers to 3D print optics: hardware, software, process and materials | Series A / Dec 01, 2013 | ||
| Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexeddetection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland. | $32.9M / Series E / Nov 05, 2013 | ||
| Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexeddetection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland. | $37.8M / Series D / Dec 12, 2012 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does PMV Tina Fund invest in?
PMV Tina Fund invests primarily in Manufacturing, Industrial and Eyewear startups, most often at Series D and Series A stage. Most of the 6 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does PMV Tina Fund invest in?
PMV Tina Fund typically joins rounds of $22M–$38M at Series D. These are whole funding-round sizes, not PMV Tina Fund's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds PMV Tina Fund took part in.
When did PMV Tina Fund last invest?
The most recent investment recorded for PMV Tina Fund closed in Sep 2016. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
